Glycolic acid
PreclinicalSmall molecule
Glycolic acid is one of 9 small molecule programs targeting Pediatric Patients. It is currently in Preclinical.
1
Indications
2
Total Trials
0
Active Trials
8
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
10 competitors in Pediatric Patients
#DrugCompanyPhaseTrials
1Ibsrela
AArdelyx
Phase 3
Blood Withdrawn
Emergent BioSolutionsPhase 3
Nsaids
RochePhase 3
Lexiscan
AstellasPhase 2
Bupivacaine Liposome
Pacira Pharmaceuticals, IncPhase 3
Joenja
PPharming Technologies B.V.
Phase 3
FCN-159
SShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
Phase 2
Local Anaesthetic
CCali Pharmaceuticals LLC
Preclinical
Glycolic acid
UUniversity of Pennsylvania
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Trichloroacetic Acid1 trial
Modified Jessner's Solution With Trichloroacetic Acid Versus Glycolic Acid With Trichloroacetic Acid
Unknown status·—·Phase 4·NCT03153852·30 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Glycolic acid. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- UUniversity of Pennsylvania